/주식/DRTSW
DRTSW

DRTSW

Alpha Tau Medical Ltd. Warrant

$0.245+0.000 (0.000%)

실시간 가격

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$0.000

고가

$0.000

저가

$0.000

거래량

0.00M

기업 기본 정보

거래 통계

관련 뉴스

GlobeNewswire

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

- Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, showing >90% disease control rate, impressive overall

더 보기
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire

Alpha Tau to Participate in May Investor Conferences

JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today

더 보기
Alpha Tau to Participate in May Investor Conferences